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PValvular Heart Disease
Is It Reasonable to Treat All Calcified
Stenotic Aortic Valves With a Valved Stent?
Results From a Human Anatomic Study in Adults
Rachid Zegdi, MD, PHD,*†‡ Vlad Ciobotaru, MD,*† Miléna Noghin, MD,† Ghassan Sleilaty, MD,†
Antoine Lafont, MD, PHD,‡§ Christian Latrémouille, MD, PHD,*† Alain Deloche, MD,*†
Jean-Noël Fabiani, MD*†‡
Paris, France
Objectives This study was designed to study the behavior of a stent deployed inside human stenotic aortic valves.
Background Endovascular valved stent (VS) implantation is a promising new therapy for patients with severe calcific aortic
stenosis (AS). The precise characteristics of stent deployment in humans have been poorly studied so far.
Methods Thirty-five patients with severe AS were included in the study. Sixteen patients (46%) had bicuspid aortic valves.
A self-expandable stent specifically designed for VS implantation was deployed intraoperatively inside the aortic
valve before surgical aortic valve replacement.
Results In tricuspid aortic valves, the shape of stent deployment was circular, triangular, or elliptic in 68%, 21%, or 11%, re-
spectively. Noncircular stent deployment was frequent in bicuspid aortic valves (the elliptic deployment being the rule
[79%]), and stent underdeployment was constant. The incidence of gaps between the stent external surface and the
aortic valve did not differ between tricuspid and bicuspid valves (58% vs. 43%; p 0.49). Sharp calcific excrescences
protruding inside the stent lumen were present in 3 cases (9%). Ex vivo study of a homemade VS confirmed that the regu-
larity of the coaptation line of the leaflets was critically dependent on the presence or the absence of stent misdeployment.
Conclusions Stent misdeployment was constant in bicuspid valves and occurred in one-third of cases of tricuspid valves. Pre-
mature failure of implanted VS (secondary to valve distortion or traumatic injury to the leaflets by calcific excres-
cences) might be an important concern in the future. (J Am Coll Cardiol 2008;51:579–84) © 2008 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.10.023r
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sortic stenosis (AS) is the most frequent valvular disease in
estern countries, and its incidence is expected to increase
ith population aging. Until recently, surgical aortic valve
eplacement (AVR) was the only effective treatment for the
ost severe forms, providing relief of symptoms and an
ncrease in life expectancy (1).
Recently, endovascular aortic valve implantation (AVI)
as been proved to be feasible in AS, using either self- or
alloon-expandable valved stents (VS) (2–4). Endovascular
VI was first performed in compassionate cases and then in
igh-risk surgical patients. However, AVI is not AVR,
ecause the native aortic valve is preserved in the former and
rom the *Université René Descartes, Paris, France; †AP-HP, Assistance Publique-
ôpitaux de Paris, Service de Chirurgie Cardio-Vasculaire, Hôpital Européen
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uropéen Georges Pompidou, Paris, France. Dr. Zegdi is a stock owner of Cormove,
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Manuscript received June 21, 2007; revised manuscript received September 18,
007, accepted October 8, 2007.emoved in the latter. Preservation of the native valve during
he endovascular procedure may be responsible, per se, for
omplications such as coronary obstruction or perivalvular
eakage (2–4).
Recourse to percutaneous AVI is expected to increase in the
uture. However, the actual clinical experience remains limited,
nd many problems need to be solved. Aside from coronary
bstruction and perivalvular leakage, conservation of the native
ortic valve may lead to other, still unknown complications.
hether their occurrence depends on the anatomic type of the
ortic valve, that is, bicuspid or tricuspid, is also unanswered.
In an attempt to elucidate these 2 questions, a human
natomic study was undertaken in patients scheduled for
onemergent surgical AVR.
aterials and Methods
uring a 5-month period, 35 patients (15 men; median age
1.5 years, range 40 to 90 years) with severe AS and
cheduled for AVR were included in the study. Median
reoperative aortic valve area was 0.7 cm2 (range 0.3 to 1 cm2),
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Valved Stents in Aortic Stenosis February 5, 2008:579–84and mean systolic transaortic
valve gradient (median) was 43
mm Hg (range 10 to 92 mm
Hg). Main pre-operative clini-
cal and echocardiographic data
are reported in Tables 1 and 2.
The study was approved by the
local institutional review board,
and all patients gave their in-
formed consent.
A braided nitinol self-expandable stent from Laboratoires
erouse (Ivry-le-Temple, France) was used for intraopera-
ive aortic valve “stenting.” The stent was designed specif-
cally for endovascular valve replacement (5). Its diameter at
est was 26 mm and was calibrated to develop a radial force
f around 1 kg when deployed in a 20-mm diameter orifice.
he stent was compressed by traction on a suture placed
round it and then was manually loaded into a 5-ml syringe
ith a cut distal extremity used for stent delivery.
During surgery, after cardioplegic arrest of the heart, the
scending aorta was opened and the aortic valve exposed.
he distal extremity of the syringe was positioned inside the
xposed aortic valve. The stent was delivered under visual
ontrol inside the aortic valve by slowly pushing the piston
f the syringe. Then, the final stent deployment was
arefully analyzed. The shape of the deployed stent was
oticed, and a special attention was given to the presence of
ny gaps between the stent external surface and the leaflets’
nner surface. These gaps are likely to be the anatomical cause
f the periprosthetic leaks observed in patients after percuta-
eous AVI. The gaps were checked with an oblique hook the
ame way perivalvular dehiscence after prosthetic valve replace-
ent is looked for. Once the analysis was achieved, the stent
as retrieved with a surgical forceps, and the AVR was
erformed. The aortic valve “stenting” lasted no more than
min.
To analyze the impact of stent deployment on valve
eometry, a homemade pericardial VS was constructed.
reoperative Clinical Characteristics andostoperative Out ome of the Study Population
Table 1 Preoperative Clinical Characteristics andPostoperative Outcome of the Study Population
Baseline Characteristics n (%) or Median (Range)
Age (yrs) 71.5 (40–90)
Gender (M/F) 15 (43)/20 (57)
Systemic hypertension 20 (57)
Diabetes mellitus 5 (14)
Coronary artery disease 14 (40)
Renal failure requiring hemodialysis 1 (3)
Post-operative outcome
30-day mortality 1 (3)
Low cardiac output syndrome 3 (9)
Reoperation for bleeding 1 (3)
Myocardial infarction 0
Stroke 0
Reoperation for bleeding 1 (3)
Abbreviations
and Acronyms
AS  aortic stenosis
AVI  aortic valve
implantation
AVR  aortic valve
replacement
VS  valved stentU
Mediastinitis 1 (3)his valve was calibrated for implantation inside a circular
rifice with a 20-mm diameter and was also implanted in a
riangular (equilateral) or an elliptic (0.73 eccentricity)
rifice with a circumference identical to that of the circular
rifice. Implantation was also performed in a 17-mm
ircular orifice to mimic the behavior of an oversized VS.
he influence of annular calcifications located close to a VS
ommissure was also studied; this was mimicked by the
resence of a bulging inside a circular orifice.
Data are expressed as median (range) for continuous vari-
bles and as percentage for categorical variables. Comparisons
etween categorical variables were performed with the Fischer
xact test. A p value 0.05 was considered significant.
esults
icuspidy was present in 16 patients (46%). Stent delivery
as impossible in 2 patients (6%) who had severely stenotic
icuspid valves.
After deployment, the aortic cross section of the stent
ould be basically categorized into 3 aspects that were
rossly circular, elliptic, or triangular (Fig. 1). The stent
eployment was highly dependent on valve anatomy
Table 3). The circular deployment was observed in 15
atients (45%), significantly more frequently in tricuspid
han in bicuspid valves (68% [n  13] vs. 14% [n  2]; p 
.004). The triangular aspect, usually mild, was seen mainly
n tricuspid valves (n  4; 21% of tricuspid valves). This
spect reflected the calcified leaflets’ rigidity, preventing
hem from being sufficiently bent and correctly applied
gainst the stent’s external surface. The elliptic aspect was
ommon in bicuspid valves (n 11; 79% of bicuspid valves).
In tricuspid valves, the median deployed stent’s external
iameter was 19 mm (range 17 to 20 mm) for the 13 cases
ith a circular stent deployment. The median aortic annulus
iameter (as determined from the preoperative transthoracic
chocardiographic measurement) was 18 mm (range 17 to
1 mm). Underdeployment (arbitrarily defined as a 3 mm
ifference between the aortic annulus and the stent external
iameter) was absent.
In bicuspid valves, the external diameter of the circularly
eployed stent and of the aortic annulus were 18 and 21 mm
n case 1 and 17 and 21 mm in case 2, respectively.
re-Operative Echocardiographicata of the Study Population
Table 2 Pre-Operative EchocardiographicData of the Study Population
n (%) or Median (Range)
Aortic valve area (cm2) 0.7 (0.3–1)
Mean aortic gradient (mm Hg) 43 (10–92)
Aortic annulus diameter (mm) 19 (17–22)
Ejection fraction (%) 65 (20–87)
Ejection fraction 30% 2 (6)
Left ventricular end-diastolic diameter (mm) 51 (36–65)
Septal thickness (mm) 12 (9–16)nderdeployment was present in both cases.
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February 5, 2008:579–84 Valved Stents in Aortic StenosisA gap between the stent external surface and the inner
urface of the aortic valve was identified in 17 patients
49%). Theses gaps were located exclusively at the level of
he commissures. Their incidence was not dependent on the
alve pathology (58% [n  11] in tricuspid vs. 43% [n  6]
n bicuspid valves; p  0.49). However, the presence of a
eriprosthetic gap depended on the shape of stent deploy-
ent (Fig. 2). The highest rate (100%) was observed with
he triangular shape and the lowest with the circular one
33%). In tricuspid valves, the gaps involved 1, 2, or 3
ommissures in 7 (37%), 4 (21%), and 0 cases, respectively.
The aortic leaflets’ ventricular surface was always irregu-
ar, and calcifications almost constantly crossed the stent
rame. These calcifications were usually small, round, and
mooth (Fig. 1). In some cases (n  3; 9%), however, these
alcifications were particularly sharp, protruding into the
tent lumen (Fig. 3).
The anchorage of the present stent to the surrounding
issue was judged firm by surgeons, and its removal was
mpossible without partial recompression. Aortic valve re-
lacement was performed with a bioprosthetic or a mechan-
cal valve in 31 (89%) and 4 (11%) patients, respectively.
Figure 1 Different Shapes of Stent Deployment Encountered
Circular (A), triangular (B), and elliptic (C and D). Note the round calcifications cro
tent Shape After Deploymentccording to Aortic Valve Pathology
Table 3 Stent Shape After DeploymentAccording to Aortic Valve Pathology
Stent Shape Tricuspidy (n  19) Bicuspidy (n  14)
Circular, n (%) 13 (68) 2 (14)
Elliptic, n (%) 2 (11) 11 (79)Triangular, n (%) 4 (21) 1 (7)After implantation of the homemade VS inside a circular
0-mm orifice, the coaptation line of the leaflets was regular
nd symmetric, reproducing the “Mercedes sign” (Fig. 4). In
ll other circumstances (undersized circular orifice, elliptic
r triangular orifice, asymmetric circular orifice), the coap-
ation line was disorganized, reflecting leaflet distortion
Figs. 4 and 5). The severity of valve distortion markedly
epended on the location of the commissures inside the
riangular orifice (Fig. 6).
iscussion
ndovascular AVI has recently been proved feasible in AS
sing either self- or balloon-expandable VS (2–4). This
romising new therapy might be beneficial to a great
umber of patients at high surgical risk or even patients for
the stent frame.
Figure 2 Incidence of Peri-Stent Gaps According to the AorticssingValve Anatomy and the Shape of Stent Deployment
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Valved Stents in Aortic Stenosis February 5, 2008:579–84hom surgery is denied. The few clinical series currently
vailable have pointed out several procedure-related com-
lications, such as valve migration, coronary obstruction, or
erivalvular leak (2–4).
Concerns have been raised regarding the potential trau-
atic injury to the pericardial leaflets of the current VS
Figure 3 Sharp Calcific Excrescences Crossing the
Stent Frame, Protruding Inside the Aortic Lumen
Figure 4 Influence of Size or Shape of the Orifice on the Valved
No leaflet distortion was present with the valved stent (VS) deployed inside the cir
Conversely, distortion occurred after deployment of the VS in an elliptic (B), a triauring the crimping or loading process into the delivery
atheter. For some models, VS deployment requires balloon
ilation. The friction of the pericardial leaflets against the stent
rame during deployment may also alter their structure or their
echanical properties, with potential negative effects on long-
erm durability (3). Mid-term or long-term follow-up are still
acking, hence the impact of these potentially deleterious
rocesses on VS durability remains unknown.
The results of the present study suggest that durability of
he VS implanted inside a stenotic aortic valve might also be
ltered through other mechanisms. In 9% of the cases, sharp
alcific excrescences protruded inside the stent lumen.
epeated contact with a pericardial (or a polymeric) leaflet
uring the aperture-closure cycle of the valve may lead to
eaflet perforation and valve dysfunction. Such lesions have
een described by surgeons during bioprosthetic valve re-
lacement when suture knots were left too long (6). Only
ufficiently covered VS might be protected from the poten-
ially harmful effect of these excrescences when the calcific
ortic valve is left in place.
The major finding of this study was the high incidence of
tent misdeployment (100% in bicuspid valves; one-third in
ricuspid valves). For optimal functioning, VS requires an
dequately sized cylindrical deployment of the stent part
upporting the leaflets. Any stent misdeployment may lead
t Deployment
rifice with a 25-mm diameter (A).
(C), or an undersized circular orifice (D).Sten
cular o
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February 5, 2008:579–84 Valved Stents in Aortic Stenosiso valve distortion (Figs. 4 to 6). Valve distortion increases
tress on 1 or more leaflets, especially at the level of the
ommissures, resulting in premature failure by leaflet tear or
brosis, as demonstrated in an animal study (7).
Valve distortion may also occur despite circular stent deploy-
ent (Fig. 4). Such a situation may theoretically be observed
ith oversized VS implantation. Oversizing has been proposed
y others (4,8) to reduce the incidence of periprosthetic leak. If
he aortic valve and/or annulus do not strictly accommodate
he oversized VS, valve distortion may occur because of excess
f pericardial tissue relatively to the stent orifice area.
Calcific bicuspidy is a frequent condition in severe AS,
ith a 50% incidence in surgical series (9). Patients with a
icuspid aortic valve are usually younger with, therefore, a
etter post-operative long-term survival. Stent misdeploy-
ent in bicuspid valves was 100% in this anatomic study.
nderdeployment was constant owing to the limited valve
pening of bicuspid aortic valves. Furthermore, noncircular
eployment of the stent was the rule (86%), increasing VS
Figure 5 Leaflet Distortion in the Presence of Annular Calcifica
Calcification, mimicked by an irregularity (left, arrow) inside the circular orifice, lea
Figure 6 Valve Distortion Secondary to the Valved Stent Deplo
The severity of valve distortion was clearly dependent on positioning of the valved
stent commissures inside the orifice (less severe in the left panel than in the righistortion attributable to stent underdeployment. Based on
hese data, a high rate of patient–VS mismatches and of VS
remature failure secondary to valve distortion would there-
ore be expected. Because of the negative effect of patient–
rosthesis mismatch on midterm survival (10), the current
rocedural risk of endovascular VS implantation, and the
otentially increased perioperative risk of a subsequent surgical
VR, we believe that endovascular VS implantation should
ot be recommended in patients with calcific bicuspid AS.
Aortic valve regurgitation was the most prevalent valvular
omplication reported following endovascular aortic VR (2–4).
he AVR was paravalvular in origin, and its severity may be
artially reduced by balloon redilation in balloon-expandable
S (4, 9). With self-expandable VS, their incidence might
ecrease with time (3). The present anatomic study confirmed
he high incidence (58% in tricuspid valves) of peri-stent
ehiscence, which was comparable to the echocardiographic
ncidence (52%) in the series of Grube et al. (3). Leaks were
lways located at the level of commissures.
Close to One Commissure of the Deployed Valved Stent
o valve distortion (right).
t Inside a Triangular Orifice
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Valved Stents in Aortic Stenosis February 5, 2008:579–84Aortic leaflets present rough ventricular surfaces in cal-
ific AS. Round calcifications are almost constant and
ultiple on this side (Fig. 1). Despite their small size, they
ay have 2 consequences. First, their protrusion through
he stent frame may provide a better VS anchorage. Subse-
uent stent migration would therefore be impossible with-
ut a spontaneous in vivo stent recompression, an eventu-
lity rather unlikely to occur with self-expandable stents.
econd, round calcifications may favor the occurrence of
alve distortion (Fig. 5) or even periprosthetic leak. This
ay happen when part of the stent frame lies on the top of
rather large calcification, creating a gap between the
xternal stent surface and the leaflets’ internal surface.
echnically speaking, this phenomenon may occur with any
ype of stent but is less likely with braided stents, whose
rame can better accommodate this situation (as reflected by
he local deformation of the stent frame in Fig. 1). These 2
otential consequences are partly speculative and require
urther evaluation.
The present study relied on the use of a self-expandable
tent. In tricuspid aortic valve stenosis, its radial force was
ufficient to achieve an adequate circular deployment in
any cases (68%) and a firm anchorage in all cases. We do
ot believe that the use of a stiffer stent would have resulted
n better expansion in bicuspid aortic valves. In these valves,
ecause of the calcifications, the excursion of at least 1
eaflet (usually the leaflet with the raphe) (Fig. 1) is severely
estricted, even with the surgeon’s forceps. This restriction
as also previously been shown in earlier studies demon-
trating the poor results of valvuloplasty in bicuspid AS (11).
owever, it is possible that a better expansion might be
bserved in tricuspid valves (this is the subject of an ongoing
tudy), but the risk of coronary obstruction might increase
ith such stiffer stents.
It is also possible that balloon valvuloplasty before aortic
tenting (as is the case in clinical practice before VS implan-
ation) may reduce the prevalence of noncircular stent deploy-
ent by “fragmentation” of the leaflet’s calcifications. Frag-
entation might improve the pliability of the aortic valve
eaflets and, therefore, favor the circular deployment of the
tent.
Rare postmortem cases have been discussed (2,4), but no
ystematic anatomic studies from cadaveric or autopsy series
nd no radiographic studies of VS deployment have been
ublished so far. Such studies are required to corroborate or
nvalidate the present data, especially if the procedure is
ntended to be applied to a larger group of patients.
In conclusion, this first human anatomical study of
ntraoperative aortic valve stenting in patients with AS
uggested that percutaneously implanted VS might show
remature failure through 2 previously unrecognized mech-
nisms: injury to the leaflets by calcific excrescences and
1alve distortion secondary to stent misdeployment. Owing
o the relatively high incidence of these unrecognized
echanisms, physicians should wait for the mid- and
ong-term results of the procedure in high-risk patients
efore extending the indication to less risky surgical pa-
ients. The present study also has shown that stent misde-
loyment (and consequently valve distortion) was constant in
icuspidy, suggesting that percutaneous AVI may have less
avorable results in bicuspid than in tricuspid AS.
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